AllianceBernstein’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.06M | Hold |
115,200
| – | – | ﹤0.01% | 2252 |
|
2025
Q1 | $988K | Hold |
115,200
| – | – | ﹤0.01% | 2252 |
|
2024
Q4 | $1.24M | Buy |
115,200
+7,360
| +7% | +$79K | ﹤0.01% | 2217 |
|
2024
Q3 | $613K | Sell |
107,840
-13,040
| -11% | -$74.1K | ﹤0.01% | 2564 |
|
2024
Q2 | $510K | Buy |
120,880
+40,480
| +50% | +$171K | ﹤0.01% | 2658 |
|
2024
Q1 | $409K | Sell |
80,400
-7,640
| -9% | -$38.9K | ﹤0.01% | 2673 |
|
2023
Q4 | $820K | Buy |
88,040
+5,000
| +6% | +$46.6K | ﹤0.01% | 2374 |
|
2023
Q3 | $544K | Sell |
83,040
-6,560
| -7% | -$43K | ﹤0.01% | 2526 |
|
2023
Q2 | $728K | Hold |
89,600
| – | – | ﹤0.01% | 2451 |
|
2023
Q1 | $768K | Hold |
89,600
| – | – | ﹤0.01% | 2353 |
|
2022
Q4 | $830K | Hold |
89,600
| – | – | ﹤0.01% | 2374 |
|
2022
Q3 | $925K | Hold |
89,600
| – | – | ﹤0.01% | 2326 |
|
2022
Q2 | $897K | Hold |
89,600
| – | – | ﹤0.01% | 2405 |
|
2022
Q1 | $1.1M | Buy |
89,600
+200
| +0.2% | +$2.46K | ﹤0.01% | 2386 |
|
2021
Q4 | $1.55M | Hold |
89,400
| – | – | ﹤0.01% | 2266 |
|
2021
Q3 | $1.61M | Hold |
89,400
| – | – | ﹤0.01% | 2273 |
|
2021
Q2 | $2.04M | Buy |
89,400
+71,000
| +386% | +$1.62M | ﹤0.01% | 2168 |
|
2021
Q1 | $275K | Sell |
18,400
-38,200
| -67% | -$571K | ﹤0.01% | 2926 |
|
2020
Q4 | $306K | Hold |
56,600
| – | – | ﹤0.01% | 2833 |
|
2020
Q3 | $258K | Hold |
56,600
| – | – | ﹤0.01% | 2865 |
|
2020
Q2 | $278K | Buy |
56,600
+27,700
| +96% | +$136K | ﹤0.01% | 2901 |
|
2020
Q1 | $91K | Buy |
+28,900
| New | +$91K | ﹤0.01% | 2968 |
|
2018
Q2 | – | Sell |
-29,700
| Closed | -$82K | – | 3099 |
|
2018
Q1 | $82K | Hold |
29,700
| – | – | ﹤0.01% | 2961 |
|
2017
Q4 | $96K | Hold |
29,700
| – | – | ﹤0.01% | 2958 |
|
2017
Q3 | $123K | Hold |
29,700
| – | – | ﹤0.01% | 3008 |
|
2017
Q2 | $158K | Buy |
+29,700
| New | +$158K | ﹤0.01% | 3022 |
|